Announcement • Jun 30
Longmaster Information & Technology Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026 Longmaster Information & Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026 Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Xiaozhou Yang was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 28
Longmaster Information & Technology Co., Ltd., Annual General Meeting, May 29, 2026 Longmaster Information & Technology Co., Ltd., Annual General Meeting, May 29, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Guiyang, Guizhou China Announcement • Mar 31
Longmaster Information & Technology Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Longmaster Information & Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Announcement • Dec 31
Longmaster Information & Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Longmaster Information & Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Announcement • Sep 30
Longmaster Information & Technology Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Longmaster Information & Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Announcement • Jul 02
Longmaster Information & Technology Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Longmaster Information & Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Announcement • Apr 25
Longmaster Information & Technology Co., Ltd., Annual General Meeting, May 16, 2025 Longmaster Information & Technology Co., Ltd., Annual General Meeting, May 16, 2025, at 15:00 China Standard Time. Location: 2F, No. 31, Changling South Road, Jinyang Science and Technology Industrial Park, National High-tech Industrial Development Zone, Guiyang, Guizhou China Announcement • Mar 31
Longmaster Information & Technology Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Longmaster Information & Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Announcement • Dec 31
Longmaster Information & Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Longmaster Information & Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.06 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.06 in 3Q 2023). Revenue: CN¥114.1m (down 4.4% from 3Q 2023). Net income: CN¥16.9m (down 14% from 3Q 2023). Profit margin: 15% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 5% per year. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥14.15, the stock trades at a trailing P/E ratio of 79.1x. Average trailing P/E is 119x in the Healthcare Services industry in China. Total returns to shareholders of 16% over the past three years. Announcement • Oct 15
Longmaster Information & Technology Co., Ltd. Announces Interim Cash Dividend on A Shares for the Year 2024, Payable on 21 October 2024 Longmaster Information & Technology Co., Ltd. announced interim cash dividend of CNY 0.1000000 per ten A shares (tax included) for the year 2024. Record date: 18 October 2024. Ex-date: 21 October 2024. Payment date: 21 October 2024. New Risk • Sep 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Announcement • Sep 30
Longmaster Information & Technology Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Longmaster Information & Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 30, 2024 New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. This is currently the only risk that has been identified for the company. New Risk • Sep 10
New major risk - Revenue and earnings growth Earnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.051 (vs CN¥0.057 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.051 (down from CN¥0.057 in 2Q 2023). Revenue: CN¥104.6m (down 14% from 2Q 2023). Net income: CN¥17.7m (down 13% from 2Q 2023). Profit margin: 17% (in line with 2Q 2023). Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 3% per year. Announcement • Jun 29
Longmaster Information & Technology Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Longmaster Information & Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Announcement • Apr 24
Longmaster Information & Technology Co., Ltd., Annual General Meeting, May 16, 2024 Longmaster Information & Technology Co., Ltd., Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: 2F, No. 31, Changling South Road, Jinyang Science and Technology Industrial Park, National High-tech Industrial Development Zone, Guiyang, Guizhou China Reported Earnings • Apr 24
First quarter 2024 earnings released: EPS: CN¥0.019 (vs CN¥0.063 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.019 (down from CN¥0.063 in 1Q 2023). Revenue: CN¥79.5m (down 26% from 1Q 2023). Net income: CN¥6.32m (down 70% from 1Q 2023). Profit margin: 8.0% (down from 20% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 9% per year. Announcement • Mar 30
Longmaster Information & Technology Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024 Longmaster Information & Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥16.52, the stock trades at a trailing P/E ratio of 78.5x. Average trailing P/E is 27x in the Healthcare Services industry in Asia. Total returns to shareholders of 80% over the past three years. Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥13.25, the stock trades at a trailing P/E ratio of 63x. Average trailing P/E is 27x in the Healthcare Services industry in Asia. Total returns to shareholders of 43% over the past three years. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥11.23, the stock trades at a trailing P/E ratio of 53.4x. Average trailing P/E is 29x in the Healthcare Services industry in Asia. Total returns to shareholders of 28% over the past three years. Announcement • Dec 30
Longmaster Information & Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 Longmaster Information & Technology Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 New Risk • Nov 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.6% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). Reported Earnings • Oct 23
Third quarter 2023 earnings released: EPS: CN¥0.06 (vs CN¥0.06 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.06 (in line with 3Q 2022). Revenue: CN¥119.4m (up 2.2% from 3Q 2022). Net income: CN¥19.7m (down 4.7% from 3Q 2022). Profit margin: 17% (down from 18% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Sep 30
Longmaster Information & Technology Co., Ltd. to Report Q3, 2023 Results on Oct 23, 2023 Longmaster Information & Technology Co., Ltd. announced that they will report Q3, 2023 results on Oct 23, 2023 Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.057 (vs CN¥0.076 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.057 (down from CN¥0.076 in 2Q 2022). Revenue: CN¥121.6m (flat on 2Q 2022). Net income: CN¥20.3m (down 18% from 2Q 2022). Profit margin: 17% (down from 20% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥13.69, the stock trades at a trailing P/E ratio of 72.7x. Average trailing P/E is 100x in the Healthcare Services industry in China. Total returns to shareholders of 24% over the past three years. Valuation Update With 7 Day Price Move • Feb 16
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥14.46, the stock trades at a trailing P/E ratio of 76.8x. Average trailing P/E is 80x in the Healthcare Services industry in China. Negligible returns to shareholders over past three years. Board Change • Dec 13
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Jingwei Liu was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥12.46, the stock trades at a trailing P/E ratio of 66.2x. Average trailing P/E is 76x in the Healthcare Services industry in China. Total returns to shareholders of 3.8% over the past three years. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.06 (vs CN¥0.06 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.06 (in line with 3Q 2021). Revenue: CN¥116.8m (up 11% from 3Q 2021). Net income: CN¥20.7m (up 2.9% from 3Q 2021). Profit margin: 18% (down from 19% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 5% per year. Reported Earnings • Aug 27
Second quarter 2022 earnings released: EPS: CN¥0.076 (vs CN¥0.066 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.076 (up from CN¥0.066 in 2Q 2021). Revenue: CN¥121.0m (up 15% from 2Q 2021). Net income: CN¥24.7m (up 11% from 2Q 2021). Profit margin: 20% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 27
First quarter 2022 earnings released: EPS: CN¥0.045 (vs CN¥0.054 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.045 (down from CN¥0.054 in 1Q 2021). Revenue: CN¥102.6m (up 5.8% from 1Q 2021). Net income: CN¥15.2m (down 17% from 1Q 2021). Profit margin: 15% (down from 19% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 16% per year. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥11.79, the stock trades at a trailing P/E ratio of 69.2x. Average trailing P/E is 69x in the Healthcare Services industry in China. Negligible returns to shareholders over past three years. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.094 in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥104.9m (down 5.7% from 3Q 2020). Net income: CN¥20.1m (down 39% from 3Q 2020). Profit margin: 19% (down from 30% in 3Q 2020). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Oct 09
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥12.83, the stock trades at a trailing P/E ratio of 61.7x. Average trailing P/E is 60x in the Healthcare Services industry in China. Total returns to shareholders of 2.5% over the past three years. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.066 (vs CN¥0.031 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥105.6m (up 4.8% from 2Q 2020). Net income: CN¥22.2m (up 138% from 2Q 2020). Profit margin: 21% (up from 9.2% in 2Q 2020). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.054 (vs CN¥0.02 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥96.9m (up 16% from 1Q 2020). Net income: CN¥18.3m (up 174% from 1Q 2020). Profit margin: 19% (up from 8.0% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year whereas the company’s share price has fallen by 26% per year. Is New 90 Day High Low • Feb 02
New 90-day low: CN¥9.34 The company is down 37% from its price of CN¥14.87 on 05 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is down 15% over the same period. Is New 90 Day High Low • Jan 06
New 90-day low: CN¥10.79 The company is down 26% from its price of CN¥14.52 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is down 13% over the same period. Is New 90 Day High Low • Dec 22
New 90-day low: CN¥11.48 The company is down 22% from its price of CN¥14.80 on 24 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is down 16% over the same period. Is New 90 Day High Low • Dec 08
New 90-day low: CN¥12.51 The company is down 14% from its price of CN¥14.50 on 09 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Healthcare Services industry, which is down 16% over the same period. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥48.3m, down 47% from the prior year. Total revenue was CN¥382.6m over the last 12 months, down 16% from the prior year. Is New 90 Day High Low • Sep 24
New 90-day high: CN¥16.45 The company is up 39% from its price of CN¥11.81 on 24 June 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is down 3.0% over the same period. 
